Dana Callow

Dana Callow is the current Director at COTA Healthcare. Dana has previously worked as a General Partner at Boston Capital Ventures, a Senior Associate at Braxton Associates, and a Lead Director and Investor at PAREXEL International. Additionally, they have experience as an Applications Consultant at McDonnell Douglas Automation Company.

Dana Callow has been in the healthcare industry for over 20 years. Dana started their career in management consulting for Fortune 100 clients before moving into venture capital investing. In 1995, they joined Ilex Oncology as a director and investor. Ilex Oncology was later sold to Sanofi for $1 bb. In 2006, Dana became a Lead Director and Investor at PAREXEL International, a global biopharmaceutical services organization. Dana has been with COTA Healthcare since 2017.

Dana Callow holds an MBA from the Tuck School of Business at Dartmouth and a Bachelor's Degree in Economics from Tufts University.